Pfizer Is a Great Dividend-Reinvestment Stock

Pfizer (PFE), the huge pharmaceutical company, keeps increasing its dividend year after year. In January 1982 its quarterly dividend on a split-adjusted basis was just $0.00958, and today it is $0.29, an unbelievable 2,927 percent increase.

At a closing price as of November 30, 2007 of $23.76, Pfizer's dividend yield is 4.88 percent, making it an excellent candidate for a dividend-reinvestment portfolio.

Despite a sideways stock performance for the last two years, Pfizer continues to be the largest pharmaceutical company with a market cap exceeding $150 billion, almost $50 billion in sales and a strong positive cash flow from which the company can continue to increase its dividend.

Related Articles:

Dividend Reinvestment Portfolio
Dividend-Paying Stocks Create Wealth
Why Dividends Matter

Posted December 3, 2007.